Simultaneously, KIF18B regulates β-catenin at the post-transcriptional level through interactions with the tumor suppressor gene APC. Based on the collective findings, we propose that KIF18B plays a carcinogenic role and may effectively serve as a novel prognostic biomarker of osteosarcoma. This evidence concerns the gene KIF18B and osteosarcoma.